Association of muscle fiber type with measures of obesity: A systematic review.
body mass index
glycolytic fibers
insulin resistance
muscle fiber type
obesity
oxidative fibers
type 2 diabetes mellitus
Journal
Obesity reviews : an official journal of the International Association for the Study of Obesity
ISSN: 1467-789X
Titre abrégé: Obes Rev
Pays: England
ID NLM: 100897395
Informations de publication
Date de publication:
07 2022
07 2022
Historique:
revised:
22
02
2022
received:
19
01
2022
accepted:
23
02
2022
pubmed:
17
3
2022
medline:
15
6
2022
entrez:
16
3
2022
Statut:
ppublish
Résumé
Obesity derives from an extended period of positive energy imbalance due to a complex interplay of environmental and biological factors. Muscle fiber type and physiology have been hypothesized to affect metabolism and energy expenditure and thus to affect an individual's propensity to gain weight. However, there have been conflicting reports regarding a relationship between muscle fiber type and obesity. Here, we systematically reviewed literature investigating this topic from PubMed, Web of Science, and EMBASE. Of these, 32 articles were included in our final review and analysis. Most studies (22/32) reported a significant relationship between muscle fiber-type proportion and a measure of obesity. Overall, there was a significant negative relationship between the proportion of type I fibers and body mass index (BMI) and a significant positive relationship between the proportion of type IIX fibers and BMI. Moreover, between-group comparisons indicated a greater prevalence of type IIX fibers and a lower prevalence of type I fibers in patients living with obesity relative to lean individuals. These significant relationships were confirmed in a meta-analysis of these data. The causal nature of these associations remains to be evaluated.
Types de publication
Journal Article
Meta-Analysis
Review
Systematic Review
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e13444Subventions
Organisme : CIHR
ID : FDN-143278
Pays : Canada
Informations de copyright
© 2022 World Obesity Federation.
Références
World Health Organization. Obesity and Overweight. WHO; 2021. Accessed January 8, 2022. https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight
Chooi YC, Ding C, Magkos F. The epidemiology of obesity. Obes 21st Century Epidemic. 2019;92:6-10. doi:10.1016/j.metabol.2018.09.005
Bray GA, Kim KK, Wilding JPH, World Obesity Federation. Obesity: a chronic relapsing progressive disease process. A position statement of the World Obesity Federation. Obes Rev. 2017;18(7):715-723. doi:10.1111/obr.12551
de Mello AH, Prá M, Cardoso LC, de Bona Schraiber R, Rezin GT. Incretin-based therapies for obesity treatment. Metabolism. 2015;64(9):967-981. doi:10.1016/j.metabol.2015.05.012
Patel D. Pharmacotherapy for the management of obesity. Metabolism. 2015;64(11):1376-1385. doi:10.1016/j.metabol.2015.08.001
Nudel J, Sanchez VM. Surgical management of obesity. Obes 21st Century Epidemic. 2019;92:206-216. doi:10.1016/j.metabol.2018.12.002
Stryjecki C, Alyass A, Meyre D. Ethnic and population differences in the genetic predisposition to human obesity. Obes Rev. 2018;19(1):62-80. doi:10.1111/obr.12604
Zurlo F, Larson K, Bogardus C, Ravussin E. Skeletal muscle metabolism is a major determinant of resting energy expenditure. J Clin Invest. 1990;86(5):1423-1427. doi:10.1172/JCI114857
Scott W, Stevens J, Binder-Macleod SA. Human skeletal muscle fiber type classifications. Phys Ther. 2001;81(11):1810-1816. doi:10.1093/ptj/81.11.1810
Talbot J, Maves L. Skeletal muscle fiber type: using insights from muscle developmental biology to dissect targets for susceptibility and resistance to muscle disease. WIREs Dev Biol. 2016;5(4):518-534. doi:10.1002/wdev.230
Behan WMH, Cossar DW, Madden HA, McKay IC. Validation of a simple, rapid, and economical technique for distinguishing type 1 and 2 fibres in fixed and frozen skeletal muscle. J Clin Pathol. 2002;55(5):375-380. doi:10.1136/jcp.55.5.375
Brooke MH, Kaiser KK. Three “myosin adenosine triphosphatase” systems: the nature of their pH lability and sulfhydryl dependence. J Histochem Cytochem. 1970;18(9):670-672. doi:10.1177/18.9.670
Simoneau J, Bouchard C. Skeletal muscle metabolism and body fat content in men and women. Obes Res. 1995;3(1):23-29. doi:10.1002/j.1550-8528.1995.tb00117.x
Haizlip KM, Harrison BC, Leinwand LA. Sex-based differences in skeletal muscle kinetics and fiber-type composition. Phys Ther. 2015;30(1):30-39. doi:10.1152/physiol.00024.2014
Ceaser T, Hunter G. Black and White race differences in aerobic capacity, muscle fiber type, and their influence on metabolic processes. Sports Med. 2015;45(5):615-623. doi:10.1007/s40279-015-0318-7
Proctor DN, Sinning WE, Walro JM, Sieck GC, Lemon PW. Oxidative capacity of human muscle fiber types: effects of age and training status. J Appl Physiol. 1995;78(6):2033-2038. doi:10.1152/jappl.1995.78.6.2033
Farup J, Rahbek SK, Riis S, Vendelbo MH, de Paoli F, Vissing K. Influence of exercise contraction mode and protein supplementation on human skeletal muscle satellite cell content and muscle fiber growth. J Appl Physiol. 2014;117(8):898-909. doi:10.1152/japplphysiol.00261.2014
Kriketos AD, Pan DA, Lillioja S, et al. Interrelationships between muscle morphology, insulin action, and adiposity. Am J Physiol-Regul Integr Comp Physiol. 1996;270(6):R1332-R1339. doi:10.1152/ajpregu.1996.270.6.R1332
Lillioja S, Young AA, Culter CL, et al. Skeletal muscle capillary density and fiber type are possible determinants of in vivo insulin resistance in man. J Clin Invest. 1987;80(2):415-424. doi:10.1172/JCI113088
Tanner CJ, Barakat HA, Dohm GL, et al. Muscle fiber type is associated with obesity and weight loss. Am J Physiol-Endocrinol Metab. 2002;282(6):E1191-E1196. doi:10.1152/ajpendo.00416.2001
Dent R, McPherson R, Harper ME. Factors affecting weight loss variability in obesity. Metabolism. 2020;113:154388. doi:10.1016/j.metabol.2020.154388
Gerrits MF, Ghosh S, Kavaslar N, et al. Distinct skeletal muscle fiber characteristics and gene expression in diet-sensitive versus diet-resistant obesity. J Lipid Res. 2010;51(8):2394-2404. doi:10.1194/jlr.P005298
Sun G, Ukkola O, Rankinen T, Joanisse DR, Bouchard C. Skeletal muscle characteristics predict body fat gain in response to overfeeding in never-obese young men. Metab - Clin Exp. 2002;51(4):451-456. doi:10.1053/meta.2002.31324
He J, Watkins S, Kelley DE. Skeletal muscle lipid content and oxidative enzyme activity in relation to muscle fiber type in type 2 diabetes and obesity. Diabetes. 2001;50(4):817-823. doi:10.2337/diabetes.50.4.817
Chomentowski P, Coen PM, Radiková Z, Goodpaster BH, Toledo FGS. Skeletal muscle mitochondria in insulin resistance: differences in intermyofibrillar versus subsarcolemmal subpopulations and relationship to metabolic flexibility. J Clin Endocrinol Metab. 2011;96(2):494-503. doi:10.1210/jc.2010-0822
Ara I, Larsen S, Stallknecht B, et al. Normal mitochondrial function and increased fat oxidation capacity in leg and arm muscles in obese humans. Int J Obes (Lond). 2011;35(1):99-108. doi:10.1038/ijo.2010.123
Pattanakuhar S, Pongchaidecha A, Chattipakorn N, Chattipakorn SC. The effect of exercise on skeletal muscle fibre type distribution in obesity: from cellular levels to clinical application. Rev Contemp Issues Obes Sci. 2017;11(5, Supplement 1):112-132. doi:10.1016/j.orcp.2016.09.012
Brooke BS, Schwartz TA, Pawlik TM. MOOSE reporting guidelines for meta-analyses of observational studies. JAMA Surg. 2021;156(8):787-788. doi:10.1001/jamasurg.2021.0522
Franssen FME, Sauerwein HP, Ackermans MT, Rutten EPA, Wouters EFM, Schols AMWJ. Increased postabsorptive and exercise-induced whole-body glucose production in patients with chronic obstructive pulmonary disease. Metabolism. 2011;60(7):957-964. doi:10.1016/j.metabol.2010.09.004
Zhang D, Wang X, Li Y, et al. Thyroid hormone regulates muscle fiber type conversion via miR-133a1. J Cell Biol. 2014;207(6):753-766. doi:10.1083/jcb.201406068
Frontera WR, Ochala J. Skeletal muscle: a brief review of structure and function. Calcif Tissue Int. 2015;96(3):183-195. doi:10.1007/s00223-014-9915-y
He J, Kelley DE. Muscle glycogen content in type 2 diabetes mellitus. Am J Physiol-Endocrinol Metab. 2004;287(5):E1002-E1007. doi:10.1152/ajpendo.00015.2004
Toft I, Bønaa KH, Lindal S, Jenssen T. Insulin kinetics, insulin action, and muscle morphology in lean or slightly overweight persons with impaired glucose tolerance. Metabolism. 1998;47(7):848-854. doi:10.1016/S0026-0495(98)90125-1
Toft I, Lindal S, Bønaa KH, Jenssen T. Quantitative measurement of muscle fiber composition in a normal population. Muscle Nerve. 2003;28(1):101-108. doi:10.1002/mus.10373
Gavin TP, Stallings HW, Zwetsloot KA, et al. Lower capillary density but no difference in VEGF expression in obese vs. lean young skeletal muscle in humans. J Appl Physiol. 2005;98(1):315-321. doi:10.1152/japplphysiol.00353.2004
Hickey MS, Weidner MD, Gavigan KE, Zheng D, Tyndall GL, Houmard JA. The insulin action-fiber type relationship in humans is muscle group specific. Am J Physiol-Endocrinol Metab. 1995;269(1):E150-E154. doi:10.1152/ajpendo.1995.269.1.E150
Gaster M, Staehr P, Beck-Nielsen H, Schrøder HD, Handberg A. GLUT4 is reduced in slow muscle fibers of type 2 diabetic patients. Diabetes. 2001;50(6):1324-1329. doi:10.2337/diabetes.50.6.1324
Smeuninx B, Mckendry J, Wilson D, Martin U, Breen L. Age-related anabolic resistance of myofibrillar protein synthesis is exacerbated in obese inactive individuals. J Clin Endocrinol Metab. 2017;102(9):3535-3545. doi:10.1210/jc.2017-00869
Houmard JA, Weidner ML, Koves TR, Hickner RC, Cortright RL. Association between muscle fiber composition and blood pressure levels during exercise in men*. Am J Hypertens. 2000;13(6):586-592. doi:10.1016/S0895-7061(99)00259-9
Albers PH, Pedersen AJT, Birk JB, et al. Human muscle fiber type-specific insulin signaling: impact of obesity and type 2 diabetes. Diabetes. 2015;64(2):485-497. doi:10.2337/db14-0590
Hickey MS, Carey JO, Azevedo JL, et al. Skeletal muscle fiber composition is related to adiposity and in vitro glucose transport rate in humans. Am J Physiol-Endocrinol Metab. 1995;268(3):E453-E457. doi:10.1152/ajpendo.1995.268.3.E453
Malenfant P, Joanisse D, Thériault R, Goodpaster B, Kelley D, Simoneau JA. Fat content in individual muscle fibers of lean and obese subjects. Int J Obes (Lond). 2001;25(9):1316-1321. doi:10.1038/sj.ijo.0801733
Riou ME, Pigeon E, St-Onge J, et al. Predictors of cardiovascular fitness in sedentary men. Appl Physiol Nutr Metab. 2009;34(2):99-106. doi:10.1139/h08-144
Kristensen D, Prats C, Larsen S, Ara I, Dela F, Helge JW. Ceramide content is higher in type I compared to type II fibers in obesity and type 2 diabetes mellitus. Acta Diabetol. 2013;50(5):705-712. doi:10.1007/s00592-012-0379-0
Stuart CA, McCurry MP, Marino A, et al. Slow-twitch fiber proportion in skeletal muscle correlates with insulin responsiveness. J Clin Endocrinol Metab. 2013;98(5):2027-2036. doi:10.1210/jc.2012-3876
Stuart CA, South MA, Lee ML, et al. Insulin responsiveness in metabolic syndrome after eight weeks of cycle training. Med Sci Sports Exerc. 2013;45(11):2021-2029. doi:10.1249/MSS.0b013e31829a6ce8
Krotkiewski M, Seidell JC, Björntorp P. Glucose tolerance and hyperinsulinaemia in obese women: role of adipose tissue distribution, muscle fibre characteristics and androgens. J Intern Med. 1990;228(4):385-392. doi:10.1111/j.1365-2796.1990.tb00250.x
Fry CS, Noehren B, Mula J, et al. Fibre type-specific satellite cell response to aerobic training in sedentary adults. J Physiol. 2014;592(12):2625-2635. doi:10.1113/jphysiol.2014.271288
Helge J, Fraser A, Kriketos A, et al. Interrelationships between muscle fibre type, substrate oxidation and body fat. Int J Obes (Lond). 1999;23(9):986-991. doi:10.1038/sj.ijo.0801030
Karjalainen J, Tikkanen H, Hernelahti M, Kujala UM. Muscle fiber-type distribution predicts weight gain and unfavorable left ventricular geometry: a 19 year follow-up study. BMC Cardiovasc Disord. 2006;6(1):2. doi:10.1186/1471-2261-6-2
Kriketos A, Baur L, O'Connor J, et al. Muscle fibre type composition in infant and adult populations and relationships with obesity. Int J Obes (Lond). 1997;21(9):796-801. doi:10.1038/sj.ijo.0800476
Larsson H, Daugaard JR, Kiens B, Richter EA, Ahrén B. Muscle fiber characteristics in postmenopausal women with normal or impaired glucose tolerance. Diabetes Care. 1999;22(8):1330-1338. doi:10.2337/diacare.22.8.1330
Taylor DL, Jackson AU, Narisu N, et al. Integrative analysis of gene expression, DNA methylation, physiological traits, and genetic variation in human skeletal muscle. Proc Natl Acad Sci. 2019;116(22):10883-10888. doi:10.1073/pnas.1814263116
Serrano N, Colenso-Semple LM, Lazauskus KK, et al. Extraordinary fast-twitch fiber abundance in elite weightlifters. PLOS One. 2019;14(3):e0207975. doi:10.1371/journal.pone.0207975
Wade AJ, Marbut MM, Round JM. Muscle fibre type and aetiology of obesity. The Lancet. 1990;335(8693):805-808. doi:10.1016/0140-6736(90)90933-V
Salomon F, Cuneo RC, Umpleby AM, Sönksen PH. Interactions of body fat and muscle mass with substrate concentrations and fasting insulin levels in adults with growth hormone deficiency. Clin Sci. 1994;87(2):201-206. doi:10.1042/cs0870201
Svendsen OL, Krotkiewski M, Hassager C, Christiansen C. Effects on muscle of dieting with or without exercise in overweight postmenopausal women. J Appl Physiol. 1996;80(4):1365-1370. doi:10.1152/jappl.1996.80.4.1365
Fuku N, Kumagai H, Ahmetov II. Chapter Fourteen-Genetics of muscle fiber composition. In: Barh D, Ahmetov II, eds. Sports, Exercise, and Nutritional Genomics. Academic Press; 2019:295-314. doi:10.1016/B978-0-12-816193-7.00014-2
Wilson JM, Loenneke JP, Jo E, Wilson GJ, Zourdos MC, Kim JS. The effects of endurance, strength, and power training on muscle fiber type shifting. J Strength Cond Res. 2012;26(6):1724-1729. doi:10.1519/JSC.0b013e318234eb6f
Erion KA, Corkey BE. Hyperinsulinemia: a cause of obesity? Curr Obes Rep. 2017;6(2):178-186. doi:10.1007/s13679-017-0261-z
Corkey BE. Banting Lecture 2011: hyperinsulinemia: cause or consequence? Diabetes. 2011;61(1):4-13. doi:10.2337/db11-1483
Mehran AE, Templeman NM, Brigidi GS, et al. Hyperinsulinemia drives diet-induced obesity independently of brain insulin production. Cell Metab. 2012;16:723-737. doi:10.1016/j.cmet.2012.10.019
Vekic J, Zeljkovic A, Stefanovic A, Jelic-Ivanovic Z, Spasojevic-Kalimanovska V. Obesity and dyslipidemia. Obes 21st Century Epidemic. 2019;92:71-81. doi:10.1016/j.metabol.2018.11.005
Templeman NM, Skovsø S, Page MM, Lim GE, Johnson JD. A causal role for hyperinsulinemia in obesity. J Endocrinol. 2017;232(3):R173-R183. doi:10.1530/JOE-16-0449
McArdle WD, Katch FI, Katch VL. Exercise Physiology: Nutrition, Energy, and Human Performance. Lippincott Williams & Wilkins; 2010.
Wong KE, Mikus CR, Slentz DH, et al. Muscle-specific overexpression of PGC-1α does not augment metabolic improvements in response to exercise and caloric restriction. Diabetes. 2014;64(5):1532-1543. doi:10.2337/db14-0827
Larrouy D, Barbe P, Valle C, et al. Gene expression profiling of human skeletal muscle in response to stabilized weight loss. Am J Clin Nutr. 2008;88(1):125-132. doi:10.1093/ajcn/88.1.125
Rothman KJ. BMI-related errors in the measurement of obesity. Int J Obes (Lond). 2008;32(3):S56-S59. doi:10.1038/ijo.2008.87
Nuttall FQ. Body mass index: obesity, BMI, and health: a critical review. Nutr Today. 2015;50(3):117-128. doi:10.1097/NT.0000000000000092
Heinrich KM, Jitnarin N, Suminski RR, et al. Obesity classification in military personnel: a comparison of body fat, waist circumference, and body mass index measurements. Mil Med. 2008;173(1):67-73. doi:10.7205/MILMED.173.1.67
Ball S, Swan PD, Altena TS. Skinfold assessment: accuracy and application. Meas Phys Educ Exerc Sci. 2006;10(4):255-264. doi:10.1207/s15327841mpee1004_3
Hume P, Marfell-Jones M. The importance of accurate site location for skinfold measurement. J Sports Sci. 2008;26(12):1333-1340. doi:10.1080/02640410802165707
Adab P, Pallan M, Whincup PH. Is BMI the best measure of obesity? BMJ. 2018;360:k1274. doi:10.1136/bmj.k1274
Denton N, Karpe F. Measuring body composition and regional fat mass accurately. Pract Diabetes. 2016;33(7):224-226. doi:10.1002/pdi.2043